Ophthalmic Viscosurgical Devices Market Key Information By Top Key Players - Alcon, Abbott Medical Optics, Carl Zeiss Meditec, Bausch & Lomb, Rayner, CIMA Technology, Precision Lens, Hyaltech, Maxigen Biotech
Ophthalmic Viscosurgical Devices Market size is set to exceed USD 790 million by 2024; according to a new research report by Global Market Insights, Inc.
(EMAILWIRE.COM, August 14, 2018 ) Ophthalmic Viscosurgical Devices Market to exceed USD 790 million by 2024 as per a new research report.
Increasing number of baby boomers globally, rising prevalence of ophthalmic ailments coupled technological advancements in ophthalmic viscosurgical devices will drive industry growth over the forecast timeframe.
Increasing number of diabetic people, who are more prone to suffer from diabetic retinopathy and blindness will fuel ophthalmic viscosurgical devices market. Rising number of cataract, cornea, vitreoretinal surgeries and increasing awareness about ocular disorders should foster market growth over the forecast period.
Delayed detection of eye disease resulting due to irregularity in eye checkup will fuel market growth over the forecast period. Scarcity of screening equipment and risk of developing increased intraocular pressure post eye surgery will hinder ophthalmic viscosurgical devices market growth over the coming years.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1134
Cohesive ophthalmic viscosurgical devices market will grow significantly during the forecast period owing to increasing adoption of the devices for maintaining space between anterior segment during eye surgery. Furthermore, cohesive devices require reduced time for removal as a result, shortening surgery time and enhancing efficiency along with reduced chances of intraocular manipulation will stimulate ophthalmic viscosurgical device market growth.
Combined devices market will witness considerable growth as it possesses properties of cohesive as well as dispersive viscosurgical devices. The devices are efficient in stabilizing tissue, coating cornea and maintain space at elevated shear rate. For instance, Healon 5 has high molecular weight along with high viscosity to break at high shear rates. Healon 5 mimics cohesive agents at low flow conditions and dispersive at high flow conditions.
Cataract surgery dominated ophthalmic viscosurgical devices market in 2016 by contributing largest revenue share. The increasing number of cataract surgeries and growing geriatric base population will drive market growth during the forecast period.
Refractive surgery market will witness significant growth over the forecast years due to increasing number of people suffering from refractive errors such as hyperopia, myopia and astigmatism. Technological advancements in refractive surgery treatment will fuel market growth .
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1134
U.S. ophthalmic viscosurgical devices market held largest revenue share in 2016 owing to increasing number of people suffering from age-related cataract and favorable reimbursement policies in the U.S. Developed healthcare infrastructure and rapid adoption of latest technology will favor market growth.
China ophthalmic viscosurgical devices market should offer lucrative opportunities over the forecast period. Growing geriatric base, lack of awareness about regular eye checkups, unmet requirements of ophthalmic care and increasing healthcare spending will fuel market growth.
Few industry players are Abbott Medical Optics, Bausch & Lomb, CIMA Technology, Hyaltech, Bohus Biotech, Sidapharm, Alcon, Carl Zeiss Meditec, Rayner, Precision Lens, Maxigen Biotech and SD Healthcare. Key industry players are consolidating their market position by introducing new technologically advanced products to the market. Partnerships and strategic collaborations are key strategies followed by the market players.
Increasing number of baby boomers globally, rising prevalence of ophthalmic ailments coupled technological advancements in ophthalmic viscosurgical devices will drive industry growth over the forecast timeframe.
Increasing number of diabetic people, who are more prone to suffer from diabetic retinopathy and blindness will fuel ophthalmic viscosurgical devices market. Rising number of cataract, cornea, vitreoretinal surgeries and increasing awareness about ocular disorders should foster market growth over the forecast period.
Delayed detection of eye disease resulting due to irregularity in eye checkup will fuel market growth over the forecast period. Scarcity of screening equipment and risk of developing increased intraocular pressure post eye surgery will hinder ophthalmic viscosurgical devices market growth over the coming years.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1134
Cohesive ophthalmic viscosurgical devices market will grow significantly during the forecast period owing to increasing adoption of the devices for maintaining space between anterior segment during eye surgery. Furthermore, cohesive devices require reduced time for removal as a result, shortening surgery time and enhancing efficiency along with reduced chances of intraocular manipulation will stimulate ophthalmic viscosurgical device market growth.
Combined devices market will witness considerable growth as it possesses properties of cohesive as well as dispersive viscosurgical devices. The devices are efficient in stabilizing tissue, coating cornea and maintain space at elevated shear rate. For instance, Healon 5 has high molecular weight along with high viscosity to break at high shear rates. Healon 5 mimics cohesive agents at low flow conditions and dispersive at high flow conditions.
Cataract surgery dominated ophthalmic viscosurgical devices market in 2016 by contributing largest revenue share. The increasing number of cataract surgeries and growing geriatric base population will drive market growth during the forecast period.
Refractive surgery market will witness significant growth over the forecast years due to increasing number of people suffering from refractive errors such as hyperopia, myopia and astigmatism. Technological advancements in refractive surgery treatment will fuel market growth .
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1134
U.S. ophthalmic viscosurgical devices market held largest revenue share in 2016 owing to increasing number of people suffering from age-related cataract and favorable reimbursement policies in the U.S. Developed healthcare infrastructure and rapid adoption of latest technology will favor market growth.
China ophthalmic viscosurgical devices market should offer lucrative opportunities over the forecast period. Growing geriatric base, lack of awareness about regular eye checkups, unmet requirements of ophthalmic care and increasing healthcare spending will fuel market growth.
Few industry players are Abbott Medical Optics, Bausch & Lomb, CIMA Technology, Hyaltech, Bohus Biotech, Sidapharm, Alcon, Carl Zeiss Meditec, Rayner, Precision Lens, Maxigen Biotech and SD Healthcare. Key industry players are consolidating their market position by introducing new technologically advanced products to the market. Partnerships and strategic collaborations are key strategies followed by the market players.
Contact Information:
Global Market Insights, Inc.
Arun Hegde
Tel: 1-888-689-0688
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Global Market Insights, Inc.
Arun Hegde
Tel: 1-888-689-0688
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results